| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/27/2006 | EP1354047B1 Methods for screening compounds that modulate lipid metabolism |
| 12/27/2006 | EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 12/27/2006 | EP1297147B1 Compositions for the diagnosis and treatment of herpes simplex virus infection |
| 12/27/2006 | EP1187806B1 Spermine:peptide-based surfactant compounds |
| 12/27/2006 | EP1183367B1 Cytotoxic t-cell epitope of the papillomavirus l1-protein and use thereof in diagnostics and therapy |
| 12/27/2006 | EP1165100B1 Methods of treating schizophrenia |
| 12/27/2006 | EP1084252B1 Nucleic acid vaccines for prevention of flavivirus infection |
| 12/27/2006 | EP1034273B1 Histamine and serotonin binding molecules |
| 12/27/2006 | EP1007549B1 Compositions and methods for highly efficient transfection |
| 12/27/2006 | CN1886515A Adenovirus-transfected primary cells and methods of pathway mapping |
| 12/27/2006 | CN1886511A Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus |
| 12/27/2006 | CN1886152A Minimization of drug oxidation in drug irradiated excipients formulations |
| 12/27/2006 | CN1884557A Method for wrapping toxoplasmosis pGRA4 eukaryotic expression plasmid using liposome and uses |
| 12/27/2006 | CN1884550A Novel subtype CaMKII alpha3 gene and clone method, expressed protein and uses |
| 12/27/2006 | CN1884543A Recombinant phycoerythrin and its preparation method and application |
| 12/27/2006 | CN1884535A Anti human CD19 mouse immune globulin variable zone gene and uses |
| 12/27/2006 | CN1884530A Human XIAP target gene siRNA expression template |
| 12/27/2006 | CN1884528A Nucleic acid sequence related with risperidone clinical curative effect |
| 12/27/2006 | CN1884526A RNA interference method for specificly and high effectively treating CSFV infection and biological formulation |
| 12/27/2006 | CN1884521A Method for finding novel gene and computer system platform using same and novel gene |
| 12/27/2006 | CN1884505A Tumour related protein kinase RX17 and its uses |
| 12/27/2006 | CN1884301A Targeted function superantigen and its preparation method and use |
| 12/27/2006 | CN1884295A Oxygen deficient induction factor1 antisense oligonucleotide and its uses |
| 12/27/2006 | CN1883707A Lyophilized preparation of recombinant adenovirus and preparation method thereof |
| 12/27/2006 | CN1292070C Recombinant eukaryon expression vector capable of simultaneously expressing two antisense bFGF and uses thereof |
| 12/27/2006 | CA2549275A1 Neoplasia-specific splice variants and methods |
| 12/26/2006 | US7153951 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives |
| 12/26/2006 | US7153949 Nucleic acid encoding poly-zinc finger proteins with improved linkers |
| 12/26/2006 | US7153942 Polypeptide for use in the treatment of inflammation, rheumatoid arritis, psoriasis, and diabetic retinopathy |
| 12/26/2006 | US7153940 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 12/26/2006 | US7153839 Method of protecting erythricytes, in particular for improvement of blood cytopenia |
| 12/26/2006 | US7153827 Produced by recombinant techniques; stimulating angiogenesis for wound healing and for vascular tissue repair |
| 12/26/2006 | US7153685 Mutant estrogen receptors and mutant estrogen response element; wide variety of applications, including gene therapy, in vivo and in vitro expression |
| 12/26/2006 | US7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof |
| 12/26/2006 | US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases |
| 12/26/2006 | US7153512 Bovine immunodeficiency virus (BIV) based vectors |
| 12/26/2006 | US7153506 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family |
| 12/26/2006 | US7153501 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 12/21/2006 | WO2006135660A2 Therapies involving lymphotoxin beta receptor |
| 12/21/2006 | WO2006135493A2 A composition for wound healing and use thereof |
| 12/21/2006 | WO2006135436A2 Inhibition of gene expression and therapeutic uses thereof |
| 12/21/2006 | WO2006135027A1 Agent for treatment of wound and/or promotion of wound healing |
| 12/21/2006 | WO2006134692A1 Angiogenetic agent containing adrenomedulin as the active ingredient |
| 12/21/2006 | WO2006122242A3 Compositions and methods for the treatment of inflammatory bowel disease utilizing nf-kb decoy polynucleotides |
| 12/21/2006 | WO2006109044A3 Selective modulation of tumour necrosis factor receptors in therapy |
| 12/21/2006 | WO2006108474A3 Use of a galectin-1-trageted rnai-based approach for the treatment of cancer |
| 12/21/2006 | WO2006099574A3 Cockroach allergen gene expression and delivery systems and uses |
| 12/21/2006 | WO2006086746A8 Homogeneous neural precursor cells |
| 12/21/2006 | WO2006041897A3 Chimeric vectors |
| 12/21/2006 | WO2004078922A3 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 12/21/2006 | WO2004063332A3 Cancer related genes |
| 12/21/2006 | WO2003054144A3 Human ras interacting protein |
| 12/21/2006 | US20060288432 Identification of a jak2 mutation in polycythemia vera |
| 12/21/2006 | US20060287513 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/21/2006 | US20060287502 C3b/C4b complement receptor-like molecules and uses thereof |
| 12/21/2006 | US20060287274 Phosphoepoxides, method for making same and uses |
| 12/21/2006 | US20060287273 Methods and reagents for inhibiting cell proliferation |
| 12/21/2006 | US20060287272 Methods for determining specificity of RNA silencing and for genetic analysis of the silenced gene or protein |
| 12/21/2006 | US20060287270 Methods of using redox-active surfactants to control polymer interactions |
| 12/21/2006 | US20060287269 Short interfering nucleic acid hybrids and methods thereof |
| 12/21/2006 | US20060287268 Splice-region antisense composition and method |
| 12/21/2006 | US20060287267 Controlling gene expression; viricides |
| 12/21/2006 | US20060287266 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 12/21/2006 | US20060287265 Apoptosis-specific eIF-5A and polynucleotides encoding same |
| 12/21/2006 | US20060287264 RNAi modulation of the BCR-ABL fusion gene and uses thereof |
| 12/21/2006 | US20060287263 Methods and compositions for inducing antigen-specific immune responses |
| 12/21/2006 | US20060287262 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 12/21/2006 | US20060287261 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 12/21/2006 | US20060287260 Oligonucleotides comprising a non-phosphate backbone linkage |
| 12/21/2006 | US20060287259 Compositions and methods for combined therapy of disease |
| 12/21/2006 | US20060287258 administering to the female an antibody that reduces the effect of prokineticin 1 on a prokineticin receptor to treat endometriosis; gonadotropin releasing hormone (GnRH) antagonist is selected from teverelix, abarelix, cetroelix or ganirelix antagonises the estrogen receptor |
| 12/21/2006 | US20060287240 Method of stimulating prosaposin receptor activity |
| 12/21/2006 | US20060287237 RhoB as a suppressor of cancer cell growth, cell transformation, and metastasis |
| 12/21/2006 | US20060287230 Compositions which can be used for regulating the activity of parkin |
| 12/21/2006 | US20060287228 Expression of active human factor IX in mammary tissue of transgenic animals |
| 12/21/2006 | US20060287227 Gonadal function improving agents |
| 12/21/2006 | US20060286642 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 12/21/2006 | US20060286634 Vector |
| 12/21/2006 | US20060286593 Transforming Growth Factor Alpha HI |
| 12/21/2006 | US20060286556 Autoimmune encephalomyelitis; multiple sclerosis; antagonize or inhibit CXCL13 |
| 12/21/2006 | US20060286545 Viral vectors with improved properties |
| 12/21/2006 | US20060286161 Injectable liposomal depots for delivering active ingredients |
| 12/21/2006 | US20060286140 Implants with attached silylated therapeutic agents |
| 12/21/2006 | US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis |
| 12/21/2006 | US20060286121 Adenoviral vector-based vaccines |
| 12/21/2006 | US20060286117 Neuronally expressed stem cell factor modulates angiogenesis and neural stem cell migration to areas of brain injury |
| 12/21/2006 | US20060286115 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule |
| 12/21/2006 | US20060286114 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof |
| 12/21/2006 | US20060286113 single domain antibody AFAI; binds to non-small cell lung carcinoma; kits |
| 12/21/2006 | US20060286111 Tumor necrosis factor related ligand |
| 12/21/2006 | US20060286110 Bax-responsive genes for drug target identification in yeast and fungi |
| 12/21/2006 | US20060286109 Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen |
| 12/21/2006 | US20060286087 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 12/21/2006 | US20060286085 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 12/21/2006 | US20060286083 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 12/21/2006 | US20060286082 Systems and methods for generating biological material |
| 12/21/2006 | US20060286081 Conditioning a culture medium with c-Met Transgenic Murine Hepatocytes and separating the the cells from the medium; adding mammalian cells to the conditioned culture medium; and culturing to grow, expand, and/or maintain the cells; bone marrow cells, stem cells, skin cells, natural killer cells, etc. |
| 12/21/2006 | US20060286080 Method for obtaining plasmid-dna by means of an aqueous biphasic system |
| 12/21/2006 | US20060286075 Method and compositions for treating hepatocellular cancer |
| 12/21/2006 | US20060286074 Methods for immunotherapy of cancer |